Schedule 13G ownership disclosure
Haemonetics Corp
Security class unavailable · CUSIP: 405024100
Event date: 2021-05-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,775,636
- Percent of class
- 5.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001422848-21-000151
- Form type
- SC 13G
- Filer
- Capital Research Global Investors
- CIK
- CIK 1422848
- Filed
- Jun 10, 2021
- Reporting period
- May 31, 2021
- Description
- Schedule 13G beneficial ownership